ReviewMediators of inflammation2017

Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics.

Fabrizio Cantini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.